Gene · 11277
Papers2,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,317
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases. | Arch Pharm Res | 2023 | 37354378 | PubTator, text mining | PubMed |
| Multiple RNA- and DNA-binding proteins exhibit direct transfer of polynucleotides with implications for target-site search. | Proc Natl Acad Sci U S A | 2023 | 37339225 | PubTator, text mining | PubMed |
| Migraine, chronic kidney disease and kidney function: observational and genetic analyses. | Hum Genet | 2023 | 37306871 | PubTator, text mining | PubMed |
| Irradiation-induced IFN-type-I pathway activation in prostate cancer cell lines. | Cytokine | 2023 | 37301190 | PubTator, text mining | PubMed |
| TREX1 531C/T Polymorphism and Autoantibodies Associated with the Immune Status of HIV-1-Infected Individuals. | Int J Mol Sci | 2023 | 37298611 | PubTator, text mining | PubMed |
| The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways. | Int J Mol Sci | 2023 | 37298600 | PubTator, text mining | PubMed |
| Epigenetic dysregulation from chromosomal transit in micronuclei. | Nature | 2023 | 37286593 | PubTator, text mining | PubMed |
| Preimplantation genetic testing for Aicardi-Goutières syndrome induced by novel compound heterozygous mutations of TREX1: an unaffected live birth. | Mol Cytogenet | 2023 | 37277873 | PubTator, text mining | PubMed |
| Downregulation of YAP Activity Restricts P53 Hyperactivation to Promote Cell Survival in Confinement. | Adv Sci (Weinh) | 2023 | 37267923 | PubTator, text mining | PubMed |
| Efficacy of radiotherapy in combination with first-line immunotherapy and chemotherapy for advanced lung squamous cell carcinoma: a propensity score analysis. | Front Immunol | 2023 | 37261356 | PubTator, text mining | PubMed |
| The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases. | Front Immunol | 2023 | 37261347 | PubTator, text mining | PubMed |
| Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers. | Mol Cancer Ther | 2023 | 37259805 | PubTator, text mining | PubMed |
| Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses. | Front Immunol | 2023 | 37251408 | PubTator, text mining | PubMed |
| Brain Calcifications: Genetic, Molecular, and Clinical Aspects. | Int J Mol Sci | 2023 | 37240341 | PubTator, text mining | PubMed |
| Chromosomal Instability in Genome Evolution: From Cancer to Macroevolution. | Biology (Basel) | 2023 | 37237485 | PubTator, text mining | PubMed |
| Radioimmunotherapy in colorectal cancer treatment: present and future. | Front Immunol | 2023 | 37234164 | PubTator, text mining | PubMed |
| Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations. | Cell Commun Signal | 2023 | 37221584 | PubTator, text mining | PubMed |
| Recombinant Klotho attenuates IFNγ receptor signaling and SAMHD1 expression through blocking NF-κB translocation in glomerular mesangial cells. | Int J Med Sci | 2023 | 37213666 | PubTator, text mining | PubMed |
| MYO10 regulates genome stability and cancer inflammation through mediating mitosis. | Cell Rep | 2023 | 37200188 | PubTator, text mining | PubMed |
| Immunologically relevant effects of radiation therapy on the tumor microenvironment. | Essays Biochem | 2023 | 37199227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11277/papers?page=15